Advanced Pancreatic Ductal Adenocarcinoma
Oncology·MeSH: Thromboembolism
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| CAN-2409 | Candel Therapeutics, Inc. (CADL) |
Frequently asked questions
How many drugs are in development for Advanced Pancreatic Ductal Adenocarcinoma?
BioSniper tracks 1 drug in development for Advanced Pancreatic Ductal Adenocarcinoma across 1 company.
How many clinical trials target Advanced Pancreatic Ductal Adenocarcinoma?
There are 3 clinical trials targeting Advanced Pancreatic Ductal Adenocarcinoma tracked by BioSniper.
Deep-dive into Advanced Pancreatic Ductal Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis